You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dopamine Release

Showing 1 - 25 of 5,781
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stress Response Trial (tDCS actif, tDCS Sham)

Not yet recruiting
  • Stress Response
  • tDCS actif
  • tDCS Sham
  • (no location specified)
Apr 20, 2023

Schizophrenia Trial in Changsha (Theta burst stimulation)

Not yet recruiting
  • Schizophrenia
  • Theta burst stimulation
  • Changsha, Hunan, China
    Central South University
Jul 3, 2022

MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)

Not yet recruiting
  • Major Depressive Disorder
  • Toludesvenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Sep 7, 2023

MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)

Recruiting
  • Major Depressive Disorder
  • Toludivenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Jun 14, 2023

Healthy Volunteers Trial in London (Amphetamine, TAK -041, [11C] (+)-4-propyl-(+)-4-propyl-9-hydroxynaphthoxazine (PHNO))

Completed
Has Results
  • Healthy Volunteers
  • London, United Kingdom
    Hammersmith Medicines Research
Mar 17, 2021

Imaging Extrastriatal Dopamine Release in Tobacco Smokers and

Completed
Has Results
  • Nicotine Dependence
  • New Haven, Connecticut
    Yale University
Mar 11, 2020

MDD Trial in New York (Pramipexole)

Completed
Has Results
  • Major Depressive Disorder
  • New York, New York
    New York State Psychiatric Institute
Oct 30, 2019

Cocaine Use Disorder Trial in Pittsburgh (Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan)

Recruiting
  • Cocaine Use Disorder
  • Baseline [C-11]NPA PET Scan
  • +2 more
  • Pittsburgh, Pennsylvania
    University of PIttsburgh
Jun 27, 2022

Disorder of Consciousness, Traumatic Brain Injury Trial in New York (Amantadine + L-DOPA, NMDA blocker)

Suspended
  • Disorder of Consciousness
  • Traumatic Brain Injury
  • Amantadine + L-DOPA
  • NMDA blocker
  • New York, New York
    Weill Cornell Medicine
Sep 27, 2022

MDD Trial in Tübingen (Ghrelin, Placebo)

Recruiting
  • Major Depressive Disorder
  • Tübingen, BW, Germany
    Department of Psychiatry & Psychotherapy, University of Tübingen
Apr 7, 2022

Levodopa-induced Dyskinesia, Parkinson's Disease Trial in Bunkyo (DSP-9632P 27.5 mg, DSP-9632P 82.5 mg, Placebo)

Recruiting
  • Levodopa-induced Dyskinesia
  • Parkinson's Disease
  • DSP-9632P 27.5 mg
  • +4 more
  • Bunkyo, Tokyo, Japan
    Nippon Medical School Hospital
Jun 23, 2022

Cocaine Abuse Trial run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (Brain Dopamine Reactivity, Brain

Suspended
  • Cocaine Abuse
  • Brain Dopamine Reactivity
  • Brain Dopamine Receptor
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Idiopathic Parkinson's Disease Trial in Pozzilli (PD patients H&Y=1.5-2 Medications ON, PD patients H&Y=1.5-2 Medications OFF,

Recruiting
  • Idiopathic Parkinson's Disease
  • PD patients H&Y=1.5-2 Medications ON
  • +4 more
  • Pozzilli, Isernia, Italy
    IRCSS Neuromed Hospital
May 18, 2022

Parkinson Disease 10 Trial in Vancouver (Active Exercise, Passive Exercise)

Completed
  • Parkinson Disease 10
  • Active Exercise
  • Passive Exercise
  • Vancouver, British Columbia, Canada
    Pacific Parkinson's Research Centre
Mar 15, 2021

Psychosis Trial in Albuquerque (Lumateperone, Risperidone)

Recruiting
  • Psychosis
  • Albuquerque, New Mexico
    University of New Mexico
May 25, 2023

Decision Making, Executive Function, Dopamine Trial in Berkeley (Tolcapone 200 MG, Functional Magnetic Resonance Imaging (fMRI))

Recruiting
  • Decision Making
  • +2 more
  • Tolcapone 200 MG
  • Functional Magnetic Resonance Imaging (fMRI)
  • Berkeley, California
    University of California, Berkeley
Jan 13, 2022

MDD, Dysthymia, Depression Trial in New York (L-DOPA, Placebo Oral Tablet)

Suspended
  • Major Depressive Disorder
  • +2 more
  • New York, New York
    New York State Psychiatric Institute
Jan 26, 2022

Pathophysiology of Gilles de la Tourette Syndrome. Part 1:

Not yet recruiting
  • Gilles de la Tourette Syndrome
  • Tourette Syndrome
  • PET/MR scanner
  • Leipzig, Germany
    Max Planck Institute for Human Cognitive and Brain Sciences
Feb 11, 2022

Fibromyalgia, Pain, Chronic, Chronic Pain, Widespread Trial in Zürich (Low dose naltrexone, Placebo, Bromocriptine Mesylate

Recruiting
  • Fibromyalgia
  • +2 more
  • Low dose naltrexone
  • +3 more
  • Zürich, Switzerland
    Balgrist Campus
Feb 20, 2022

Smoking, Cannabis Trial in New Haven (cannabis)

Recruiting
  • Smoking
  • Cannabis
  • New Haven, Connecticut
  • +2 more
Dec 6, 2022

Parkinson Disease, Effect of Drug Trial in Nijmegen (Hypoxic Gas Mixture)

Recruiting
  • Parkinson Disease
  • Effect of Drug
  • Hypoxic Gas Mixture
  • Nijmegen, Netherlands
    Dpt. of Physiology, Radboud University Medical Center
Apr 27, 2022

Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T

Recruiting
  • Gilles de la Tourette Syndrome
  • Tourette Syndrome
  • MRI scanner (7 Tesla)
  • Leipzig, Germany
    Max Planck Institute for Human Cognitive and Brain Sciences
Feb 10, 2022

Depression, Psychosis, Anhedonia Trial in Chapel Hill (Transdermal Estradiol, Micronized Progesterone, Matching Placebo Patch)

Recruiting
  • Depression
  • +2 more
  • Transdermal Estradiol
  • +3 more
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Dec 20, 2022

Postoperative Nausea and Vomiting Trial in Banha (Midazolam injection)

Completed
  • Postoperative Nausea and Vomiting
  • Midazolam injection
  • Banhā, Qalubia, Egypt
    Samar Rafik Mohamed Amin
Aug 13, 2022

Polymorphism-Genetic, Pain, Addiction Trial run by the NIAAA (Morphine, Placebo)

Completed
Has Results
  • Polymorphism-Genetic
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 8, 2021